Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10221543rdf:typepubmed:Citationlld:pubmed
pubmed-article:10221543lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:10221543lifeskim:mentionsumls-concept:C0752312lld:lifeskim
pubmed-article:10221543lifeskim:mentionsumls-concept:C1424650lld:lifeskim
pubmed-article:10221543lifeskim:mentionsumls-concept:C1539079lld:lifeskim
pubmed-article:10221543lifeskim:mentionsumls-concept:C1155201lld:lifeskim
pubmed-article:10221543lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:10221543pubmed:issue4lld:pubmed
pubmed-article:10221543pubmed:dateCreated1999-7-28lld:pubmed
pubmed-article:10221543pubmed:abstractTextWe previously reported that endothelin-1 induces synthesis of interleukin-6 (IL-6) via activation of protein kinase C in osteoblast-like MC3T3-E1 cells. In the present study, we further investigated whether p42/p44 mitogen-activated protein (MAP) kinase is involved in endothelin-1-induced IL-6 synthesis in these cells. Endothelin-1 stimulated p42/p44 MAP kinase activation in a dose-dependent manner in the range between 0.1 nmol/L and 0.1 micromol/L. PD98059, a specific inhibitor of the upstream kinase that activates p42/p44 MAP kinase, suppressed endothelin-1-induced IL-6 synthesis as well as endothelin-1-activated p42/p44 MAP kinase. Both p42/p44 MAP kinase activation and IL-6 synthesis induced by 12-O-tetradecanoylphorbol-13-acetate (TPA), a protein kinase C-activating phorbol ester, were reduced by PD98059. Calphostin C, a highly specific inhibitor of protein kinase C, suppressed endothelin-1-stimulated p42/p44 MAP kinase activation as well as endothelin-1-induced IL-6 synthesis. These results strongly suggest that protein kinase C-dependent p42/p44 MAP kinase activation is involved in endothelin-1-induced IL-6 synthesis in osteoblast-like cells.lld:pubmed
pubmed-article:10221543pubmed:languageenglld:pubmed
pubmed-article:10221543pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10221543pubmed:citationSubsetIMlld:pubmed
pubmed-article:10221543pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10221543pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10221543pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10221543pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10221543pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10221543pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10221543pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10221543pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10221543pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10221543pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10221543pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10221543pubmed:statusMEDLINElld:pubmed
pubmed-article:10221543pubmed:monthAprlld:pubmed
pubmed-article:10221543pubmed:issn8756-3282lld:pubmed
pubmed-article:10221543pubmed:authorpubmed-author:NiwaMMlld:pubmed
pubmed-article:10221543pubmed:authorpubmed-author:TokudaHHlld:pubmed
pubmed-article:10221543pubmed:authorpubmed-author:OtsukaTTlld:pubmed
pubmed-article:10221543pubmed:authorpubmed-author:KawamuraHHlld:pubmed
pubmed-article:10221543pubmed:authorpubmed-author:MatsunoHHlld:pubmed
pubmed-article:10221543pubmed:authorpubmed-author:UematsuTTlld:pubmed
pubmed-article:10221543pubmed:authorpubmed-author:MatsuiNNlld:pubmed
pubmed-article:10221543pubmed:authorpubmed-author:KozawaOOlld:pubmed
pubmed-article:10221543pubmed:issnTypePrintlld:pubmed
pubmed-article:10221543pubmed:volume24lld:pubmed
pubmed-article:10221543pubmed:ownerNLMlld:pubmed
pubmed-article:10221543pubmed:authorsCompleteYlld:pubmed
pubmed-article:10221543pubmed:pagination315-20lld:pubmed
pubmed-article:10221543pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:10221543pubmed:meshHeadingpubmed-meshheading:10221543...lld:pubmed
pubmed-article:10221543pubmed:meshHeadingpubmed-meshheading:10221543...lld:pubmed
pubmed-article:10221543pubmed:meshHeadingpubmed-meshheading:10221543...lld:pubmed
pubmed-article:10221543pubmed:meshHeadingpubmed-meshheading:10221543...lld:pubmed
pubmed-article:10221543pubmed:meshHeadingpubmed-meshheading:10221543...lld:pubmed
pubmed-article:10221543pubmed:meshHeadingpubmed-meshheading:10221543...lld:pubmed
pubmed-article:10221543pubmed:meshHeadingpubmed-meshheading:10221543...lld:pubmed
pubmed-article:10221543pubmed:meshHeadingpubmed-meshheading:10221543...lld:pubmed
pubmed-article:10221543pubmed:meshHeadingpubmed-meshheading:10221543...lld:pubmed
pubmed-article:10221543pubmed:meshHeadingpubmed-meshheading:10221543...lld:pubmed
pubmed-article:10221543pubmed:meshHeadingpubmed-meshheading:10221543...lld:pubmed
pubmed-article:10221543pubmed:meshHeadingpubmed-meshheading:10221543...lld:pubmed
pubmed-article:10221543pubmed:meshHeadingpubmed-meshheading:10221543...lld:pubmed
pubmed-article:10221543pubmed:meshHeadingpubmed-meshheading:10221543...lld:pubmed
pubmed-article:10221543pubmed:year1999lld:pubmed
pubmed-article:10221543pubmed:articleTitleInvolvement of p42/p44 MAP kinase in endothelin-1-induced interleukin-6 synthesis in osteoblast-like cells.lld:pubmed
pubmed-article:10221543pubmed:affiliationDepartment of Pharmacology, Gifu University School of Medicine, Japan.lld:pubmed
pubmed-article:10221543pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10221543pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:10221543pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10221543lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10221543lld:pubmed